The Effect Of Tramadol, Metamizol and Dexketoprofen Combination On Chronic Pain Development After Heart Surgery
NCT ID: NCT02660749
Last Updated: 2016-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2015-05-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multimodal Versus Opioid aNalgesia in carDiAc Surgery
NCT04987372
Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride
NCT01902134
Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride
NCT01904149
Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.
NCT04178109
Multimodal Analgesia Versus Traditional Opiate Based Analgesia
NCT03521167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA 1-4
* Euroscore value lower than 7
* Undergoned non coronary heart surgery (minithoracotomy and sternotomy)
* Intensive care has been discharged from the service in 24 hours , with patients given tramadol retard , metamizol, Dexketoprofen on postoperatif first day to discharged from the hospital.
Exclusion Criteria
* Chronic renal failure
* COPD
* Uncontrolled hypertension
* Epilepsy
* Psychiatric disease
* Malignancy
* Patients with a history of cerebrovascular disease
* Patients with ischemia
* Patients suffering from chronic pain and analgesic use
* Patients taking antidepressants and antiepileptic drug
* Off-pump technique used or redo undergo cases
* Ongoing postoperative time thoracic or mediastinal drains more than 48 hours remaining patients, bleeding or patients who received repeated revisions due to infection
* More than 24 hours remaining in intensive care patients
* Patients with long discharge duration 1 week
* Patients who discontinued due to side effects of tramadol may begin after medicines.
* Postoperative wound infection.
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tobb University of Economics and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
H. Evren Eker, Ass Prof
Role: STUDY_DIRECTOR
Baskent University Department of Anesthesiology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-PMS-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.